Donald J. Spence Sells 14,739 Shares of Integer Holdings Co. (NYSE:ITGR) Stock

Integer Holdings Co. (NYSE:ITGR - Get Free Report) Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director now owns 18,781 shares of the company's stock, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Integer Stock Performance

Shares of Integer stock traded up $0.35 during trading hours on Friday, hitting $121.25. 234,023 shares of the company were exchanged, compared to its average volume of 374,978. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The stock has a market capitalization of $4.23 billion, a price-to-earnings ratio of 36.09, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The business has a 50-day moving average of $118.75 and a 200-day moving average of $128.20.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business's revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 EPS. As a group, analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Strs Ohio acquired a new stake in shares of Integer in the first quarter valued at approximately $283,000. Intech Investment Management LLC boosted its holdings in shares of Integer by 92.8% in the 1st quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider's stock valued at $2,677,000 after purchasing an additional 10,915 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after acquiring an additional 4,873 shares during the period. Axiom Investors LLC DE acquired a new stake in Integer during the 1st quarter worth approximately $4,457,000. Finally, United Services Automobile Association purchased a new position in shares of Integer in the 1st quarter valued at $258,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analyst Upgrades and Downgrades

ITGR has been the subject of several analyst reports. KeyCorp dropped their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and raised their price objective for the company from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, Truist Financial set a $150.00 target price on shares of Integer and gave the company a "buy" rating in a report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Integer currently has a consensus rating of "Moderate Buy" and an average target price of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.